Ovarian hyperstimulation syndrome

Ovarian hyperstimulation syndrome (OHSS) is a complication of ovarian stimulation treatment (ovarian induction therapy) for in vitro fertilisation. Rarely, it may also occur as a spontaneous event in pregnancy (see spontaneous ovarian hyperstimulation later in the article).

The clinical syndrome consists of ovarian enlargement with extra-vascular accumulation of exudates leading to varying degrees of

• weight gain
• increase in abdominal circumference
• ascites
• pleural effusions
• intravascular volume depletion with hemoconcentration
• oliguria

Epidemiology

The syndrome is relatively common, occurring in ~5% of patients undergoing in vitro fertilisation (IVF).

Clinical presentation

The clinical picture may vary from abdominal distension and discomfort to potentially life-threatening capillary leak with fluid sequestration in a third space, and massive ovarian enlargement.  Pain, abdominal distention, nausea, and vomiting are frequently seen as symptoms.

Pathology

It is characterized by massive cystic ovarian enlargement and fluid shift from the intravascular compartment into the peritoneal, pleural or pericardial cavities. The vascular fluid leakage is thought to result from an increased capillary permeability of mesothelial surfaces under the action of one or several vasoactive ovarian factors produced by multiple corpora lutea. Acute pelvic pain can result from stretching of the ovarian capsule or hemorrhage/rupture of a follicle.

Risk factors

• baseline ovarian volume ⁸
• background polycystic ovaries ⁹
• low body weight ⁸
• long ovulation induction cycle duration ⁸

Markers

• serum estradiol (E₂) levels are elevated

Subtypes

Spontaneous ovarian hyperstimulation

This sub type occurs in the absence of any external stimulation. This form can occur in pregnancy ¹⁵.

There are also very rare sporadic forms which carry a genetic component. These have an association with early pubertal development and primary hypothyroidism. Ovarian stimulation in the hypothyroid child may result in estrogen production, breast development, endometrial proliferation, and vaginal bleeding. It is likely that raised TSH concentrations bind and stimulate the FSH receptor, although a similar overlap phenomenon might occur at the level of the pituitary, with enhanced TRH production stimulating the GnRH receptor with subsequent ovarian enlargement. The cystic ovarian enlargement resolves with thyroid hormone replacement. A hyperstimulation phenomenon in patients with an abnormal FSH receptor has been described.

Classification

Based on the clinical manifestation and imaging findings, OHSS can be classified into ¹²

• mild OHSS: characterized by bilateral multicystic ovarian enlargement
  • grade 1: abdominal distention and discomfort
  • grade 2: plus nausea, vomiting and/or diarrhea plus ovarian enlargement from 5 to 12 cm
• moderate OHSS: if there is associated ascites and abdominal distension
  • grade 3: features of mild OHSS plus ultrasonographic evidence of ascites
• severe OHSS: characterized by hypovolemia, hemoconcentration, thrombosis, oliguria, pleural and pericardial effusion
  • grade 4: moderate OHSS plus clinical evidence of ascites and/or hydrothorax and dyspnea
  • grade 5: grade 4 plus change in the blood volume, hemoconcentration, coagulation abnormalities and diminished kidney perfusion and function

Radiographic features

Imaging findings can be similar on ultrasound, CT and MR imaging.

Ultrasound

• typically shows bilateral symmetric enlargement of ovaries (often >12 cm in size)
• multiple cysts of varying sizes, giving the classic spoke-wheel appearance
• associated ascites and pleural +/- pericardial effusion (which is due to capillary leak) may also be present

Treatment and prognosis

The syndrome is usually self-limiting in most cases and management is mainly supportive, however, cases with fatal outcome have been reported ¹⁴. Severe cases usually require hospitalization and a close monitoring of the hematocrit, liver function, renal function, serum electrolytes and oxygen saturation.

The profoundly altered maternal environment of OHSS is a significant risk factor for miscarriage, especially when occurring in the early phase after IVF (defined as <10 days after oocyte retrieval) ¹⁶.

Complications

• hypovolemic shock with resultant
  • thromboembolic disease
  • stroke
• increased risk of ovarian torsion ⁶

Differential diagnosis

For ultrasound appearances in mild cases consider

• polycystic ovaries
  • cysts are typically small
  • no ascites or pleural effusions
• theca lutein cysts associated with gestational trophoblastic disease: some also considered a part of OHSS
• mucinous ovarian malignancy

Practical points

Familiarity with ovarian hyperstimulation syndrome and the appropriate clinical setting should help avoid the incorrect diagnosis of an ovarian cystic neoplasm. On encountering severe forms not suspected by the clinician suggesting the diagnosis may reduce both morbidity and mortality.